Volume 84, Issue 3, Pages (September 2013)

Slides:



Advertisements
Similar presentations
Increased cGMP phosphodiesterase activity mediates renal resistance to ANP in rats with bile duct ligation  Xi-Ping Ni, Massy Safai, David G. Gardner,
Advertisements

Volume 73, Issue 11, Pages (June 2008)
Volume 56, Issue 3, Pages (September 1999)
Volume 66, Issue 4, Pages (October 2004)
Volume 62, Issue 6, Pages (December 2002)
Biff F. Palmer, MD, Deborah J. Clegg, PhD  Mayo Clinic Proceedings 
Volume 78, Issue 2, Pages (July 2010)
Dong Zhou, Yingjian Li, Lin Lin, Lili Zhou, Peter Igarashi, Youhua Liu 
Volume 83, Issue 5, Pages (May 2013)
Volume 80, Issue 6, Pages (September 2011)
Renal Nerves, WNK4, Glucocorticoids, and Salt Transport
Volume 71, Issue 11, Pages (June 2007)
Volume 63, Issue 2, Pages (February 2003)
Volume 68, Issue 4, Pages (October 2005)
Volume 86, Issue 1, Pages (July 2014)
Volume 64, Issue 4, Pages (October 2003)
Volume 78, Issue 2, Pages (July 2010)
John M. Arthur, M.D.Ph.D., Shazia Shamim  Kidney International 
Carlton M. Bates, Heather Kegg, Christina Petrevski, Sandy Grady 
Proteomic analysis of the slit diaphragm complex: CLIC5 is a protein critical for podocyte morphology and function  Brian A. Pierchala, Maura R. Muñoz,
Volume 79, Issue 1, Pages (January 2011)
Volume 78, Issue 10, Pages (November 2010)
Paolo Ferrari, M.D., Zygmunt Krozowski  Kidney International 
Volume 61, Issue 6, Pages (June 2002)
A trail of research on potassium
Serine 269 phosphorylated aquaporin-2 is targeted to the apical membrane of collecting duct principal cells  Hanne B. Moeller, Mark A. Knepper, Robert.
Volume 70, Issue 6, Pages (September 2006)
Endogenous hepatocyte growth factor ameliorates chronic renal injury by activating matrix degradation pathways  Youhua Liu, Krupa Rajur, Evelyn Tolbert,
Differential expression of adenylyl cyclases in the rat nephron
Kamel S. Kamel, Martin Schreiber, Mitchell L. Halperin 
Volume 73, Issue 2, Pages (January 2008)
IL-18 is expressed in the intercalated cell of human kidney
Volume 66, Issue 2, Pages (August 2004)
Volume 57, Issue 6, Pages (June 2000)
Vasopressin in chronic kidney disease: an elephant in the room?
Down-regulation of Na+ transporters and AQP2 is responsible for acyclovir-induced polyuria and hypophosphatemia  Lúcia Andrade, Nancy A. Rebouças, Antonio.
1,25-dihydroxyvitamin D3 inhibits renal interstitial myofibroblast activation by inducing hepatocyte growth factor expression  Yingjian Li, Bradley C.
Volume 69, Issue 6, Pages (March 2006)
Volume 78, Issue 4, Pages (August 2010)
Yongji Wang, Megan L. Borchert, Hector F. DeLuca  Kidney International 
Volume 86, Issue 3, Pages (September 2014)
Volume 61, Issue 6, Pages (June 2002)
Volume 83, Issue 1, Pages (January 2013)
Volume 83, Issue 4, Pages (April 2013)
Vasopressin regulation of renal sodium excretion
Volume 5, Issue 5, Pages (May 2007)
Volume 63, Issue 4, Pages (April 2003)
Volume 78, Issue 7, Pages (October 2010)
Volume 58, Issue 2, Pages (August 2000)
Need to quickly excrete K+? Turn off NCC
Induction of heat shock protein 70 inhibits ischemic renal injury
Volume 69, Issue 2, Pages (January 2006)
Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis  H.-C. Yang, L.-J. Ma, J. Ma, A.B. Fogo 
Distribution of postsynaptic density proteins in rat kidney: Relationship to neuronal nitric oxide synthase  Akihiro Tojo, David S. Bredt, Christopher.
Volume 79, Issue 4, Pages (February 2011)
Resistance of mTAL Na+-dependent transporters and collecting duct aquaporins to dehydration in 7-month-old rats  Hassane Amlal, Catherine Wilke  Kidney.
Volume 76, Issue 1, Pages (July 2009)
Increased cGMP phosphodiesterase activity mediates renal resistance to ANP in rats with bile duct ligation  Xi-Ping Ni, Massy Safai, David G. Gardner,
Volume 80, Issue 4, Pages (August 2011)
Insulin resistance and hypertension: new insights
Volume 71, Issue 11, Pages (June 2007)
Volume 77, Issue 1, Pages (January 2010)
AT1a receptor knockout in mice impairs urine concentration by reducing basal vasopressin levels and its receptor signaling proteins in the inner medulla 
Volume 76, Issue 9, Pages (November 2009)
Estrogen downregulates the proximal tubule type IIa sodium phosphate cotransporter causing phosphate wasting and hypophosphatemia  S. Faroqui, M. Levi,
Biology of endothelin receptors in the collecting duct
Volume 74, Issue 11, Pages (December 2008)
Volume 60, Issue 3, Pages (September 2001)
Molecular biology of distal nephron sodium transport mechanisms
Nat. Rev. Nephrol. doi: /nrneph
Presentation transcript:

Volume 84, Issue 3, Pages 501-508 (September 2013) Intrarenal ghrelin receptors regulate ENaC-dependent sodium reabsorption by a cAMP- dependent pathway  Brandon A. Kemp, Nancy L. Howell, John J. Gildea, Susanna R. Keller, Shetal H. Padia  Kidney International  Volume 84, Issue 3, Pages 501-508 (September 2013) DOI: 10.1038/ki.2013.187 Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 1 Intrarenal ghrelin receptors (GRs) are localized to the collecting duct. High-power(× 400) confocal micrographs of Sprague–Dawley (SD) rat kidney labeled with antibodies to marker proteins specific for each segment: villin for proximal tubules, Tamm–Horsfall protein (THP) for thick ascending limb, calbindin-D28K (CAL) for distal convoluted tubule, and aquaporin-2 (AQP-2) for the collecting duct. As shown by the gold color in a, GRs (red) colocalize with the collecting duct marker AQP-2 (green); however, no overlap in staining is observed with distal tubule marker CAL (blue). (b) GRs (red) are completely separated from the proximal tubule marker villin (green). (c) GRs (red) do not colocalize with the thick ascending limb marker THP (green) and confirms lack of overlap with the distal tubule marker CAL (blue). The scale bar in a represents 10μm. Kidney International 2013 84, 501-508DOI: (10.1038/ki.2013.187) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 2 Intrarenal ghrelin receptors (GRs) are enriched in collecting duct membranes from renal tissue in normal rats. Following collecting duct–specific immunoprecipitation (IP) with L1-CAM (an epitope specifically present on collecting duct cells and not distal tubule cells), membranes were probed for GR expression. As shown in the composite of representative western blots, GRs are enriched in collecting duct membranes (Gel 1). To ensure the collecting duct membrane specificity of the IP, aquaporin-2 (AQP-2), a known marker of collecting duct cells, was localized to the same fraction (positive control, Gel 4); however, distal tubule marker sodium chloride cotransporter (NCC) was not present in this fraction (negative control, Gel 2). To validate our ability to detect NCC altogether, we show NCC enrichment of total renal membranes (Gel 3). IB, immunoblot. Kidney International 2013 84, 501-508DOI: (10.1038/ki.2013.187) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 3 Ghrelin-induced antinatriuresis is not observed in the presence of acute intrarenal epithelial sodium channel (ENaC) blockade. (a) Direct renal interstitial (RI) infusion of ghrelin () significantly reduces urine sodium excretion (UNaV) in normal rats. The ghrelin-induced antinatriuresis is abolished after the coinfusion of ghrelin+amiloride (), a specific blocker of the collecting duct ENaC, whereas the coinfusion of ghrelin+chlorothiazide (), a specific inhibitor of the distal tubule sodium chloride cotransporter (NCC), had no effect. Both RI infusions of amiloride () or chlorothiazide alone () induced natriuresis, ensuring adequate Na+ transporter blockade. RI infusion of 5% dextrose in water (D5W) () served as a time control and had no effect. (b) Mean arterial pressures (MAP) in response to conditions in a. RI D5W infusion (□), ghrelin infusion (■), ghrelin+amiloride (), ghrelin+chlorothiazide (), amiloride (), and chlorothiazide alone (). Results are reported as a percentage of corresponding baseline value. Data represent mean±s.e.; **P<0.01, ***P<0.001 from respective control period (two-tailed paired Student’s t-test). Analysis of variance: +P<0.05, ++P<0.01 from time control (RI D5W). Kidney International 2013 84, 501-508DOI: (10.1038/ki.2013.187) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 4 Ghrelin-induced antinatriuresis is not observed in the presence of chronic, systemic epithelial sodium channel (ENaC) blockade. (a) Urine sodium excretion (UNaV) in response to renal interstitial (RI) infusion of 5% dextrose in water (D5W) () or ghrelin (), following 72h of systemic ENaC blockade with amiloride. (□) and (■) represent UNaV in response to RI D5W or ghrelin infusion in the absence of systemic amiloride (only systemic D5W treatment), respectively. (b) Mean arterial pressure (MAP) values in response to the conditions in a. Results are reported as a percentage of corresponding baseline value. Data represent mean±s.e.; **P<0.01, ***P<0.001 from respective control period (two-tailed paired Student’s t-test). Kidney International 2013 84, 501-508DOI: (10.1038/ki.2013.187) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 5 Renal interstitial (RI) ghrelin infusion increases cortical collecting duct (CCD) apical membrane αENaC, without changes in total renal αENaC. Phosphorylated serum/glucocorticoid-regulated kinase-1 (pSGK1) also increases in response to ghrelin infusion, but not total or phosphorylated sodium chloride cotransporter (NCC). (a) CCD membrane-associated αENaC in response to RI infusion of 5% dextrose in water (D5W) (□) or ghrelin (■) after 1- or 3-h infusions. (b) Total renal αENaC protein expression in response to conditions in a. (c) Renal pSGK1/total SGK1 protein ratio in response to conditions in a. (d) Renal pT53-NCC/total NCC protein ratio in response to conditions in a. Blots in a were normalized to β-tubulin and blots in b, c, d were normalized to β-actin. Data represent mean±s.e.; **P<0.01, ***P<0.001 compared with control (two-tailed paired Student’s t-test). Kidney International 2013 84, 501-508DOI: (10.1038/ki.2013.187) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 6 Renal interstitial (RI) ghrelin infusion results in increased microdialysate cAMP levels; these levels return to baseline in the presence of adenylyl cyclase (AC) inhibition with SQ-22536. RI cAMP levels in response to RI infusions of 5% dextrose in water (D5W) (□), ghrelin (■), or the coinfusion of ghrelin+AC inhibitor SQ-22536 (). Results are reported in pmol/ml and data represent mean±s.e.; **P<0.01 from respective control period (two-tailed paired Student’s t-test). Kidney International 2013 84, 501-508DOI: (10.1038/ki.2013.187) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 7 Ghrelin-induced antinatriuresis is abolished in the presence of adenylyl cyclase (AC) inhibition with SQ-22536. (a) Urine Na+ excretion (UNaV) in response to renal interstitial (RI) infusions of 5% dextrose in water (D5W) (□), ghrelin (■), or the coinfusion of ghrelin+AC inhibitor SQ-22536 (). (b) Mean arterial pressure (MAP) in response to conditions in a. Results are reported as a percentage of corresponding baseline value. Data represent mean±s.e.; **P<0.01, ***P<0.001 from respective control period (two-tailed paired Student’s t-test). Kidney International 2013 84, 501-508DOI: (10.1038/ki.2013.187) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 8 Sodium reabsorption. Diagram illustrating the mechanism by which ghrelin receptors (GRs) stimulate sodium reabsorption in the cortical collecting duct. AC, adenylyl cyclase; PKA, protein kinase A. Kidney International 2013 84, 501-508DOI: (10.1038/ki.2013.187) Copyright © 2013 International Society of Nephrology Terms and Conditions